Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan

Background/Objective: Fixed drug eruption (FDE) is a dermatosis characterized by recurrent patches or plaques at exactly the same sites with each administration of the causative drug. Vesicles or bullae may sometimes be found, and generalized bullous fixed drug eruption (GBFDE) may be confused with...

Full description

Bibliographic Details
Main Authors: Cheng-Han Lee, Yi-Chun Chen, Yung-Tsu Cho, Chia-Ying Chang, Chia-Yu Chu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-03-01
Series:Dermatologica Sinica
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1027811712000109
id doaj-f770a00125ee4ac299697681ac92aaa3
record_format Article
spelling doaj-f770a00125ee4ac299697681ac92aaa32020-11-24T22:14:28ZengWolters Kluwer Medknow PublicationsDermatologica Sinica1027-81172012-03-01301111510.1016/j.dsi.2012.02.002Fixed-drug eruption: A retrospective study in a single referral center in northern TaiwanCheng-Han Lee0Yi-Chun Chen1Yung-Tsu Cho2Chia-Ying Chang3Chia-Yu Chu4Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Dermatology, Cathay General Hospital, Taipei, TaiwanDepartment of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanBackground/Objective: Fixed drug eruption (FDE) is a dermatosis characterized by recurrent patches or plaques at exactly the same sites with each administration of the causative drug. Vesicles or bullae may sometimes be found, and generalized bullous fixed drug eruption (GBFDE) may be confused with Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). This study aimed to investigate the clinical and pathologic features of FDE in Taiwan. Methods: A retrospective analysis evaluated patients with FDE in a referral center in Taiwan covering a period of 11 years. Clinical data, suspected etiologies, and pathology/patch test results were collected. We also compared the GBFDE cases with SJS/TEN overlap or TEN cases to find differentiating clues. Results: There were 39 FDE patients, including nine GBFDE cases. The most frequent causative drugs were non-steroidal anti-inflammatory drugs (five cases, 12.8%) and antibiotics (four cases, 10.3%). Extremities other than the hands (71.8%) were the most frequently affected sites, followed by the trunk (51.3%), mucosa (38.5%), and hands (33.3%). The average age of FDE patients was 52.2 years (median, 56 years; range, 4–86 years). Patients with GBFDE were significantly older than non-GBFDE patients (69.1±19.7 vs. 47.2±23.6, p=0.0124) and the trunk was more likely to be involved in GBFDE cases (88.9% vs. 40.0%, p=0.0197). GBFDE cases also showed tendency to have more mucosal involvement (66.7% vs. 30.0%, p=0.0631). Although similar to SJS/TEN, GBFDE cases had fewer constitutional symptoms, less mucosal involvement but had previous episodes. Histopathologically, the presence of more than two aggregated dyskeratotic keratinocytes (fire flag sign) in the epidermis was more frequently observed in SJS/TEN, whereas GBFDE had superficial and deep dermal infiltration of eosinophils and melanophages. Conclusion: FDE is one of the specialized cutaneous drug reactions and GBFDE should be kept in mind and differentiated from SJS/TEN.http://www.sciencedirect.com/science/article/pii/S1027811712000109generalized bullous fixed drug eruptionfixed drug eruptionStevens-Johnson syndrometoxic epidermal necrolysis
collection DOAJ
language English
format Article
sources DOAJ
author Cheng-Han Lee
Yi-Chun Chen
Yung-Tsu Cho
Chia-Ying Chang
Chia-Yu Chu
spellingShingle Cheng-Han Lee
Yi-Chun Chen
Yung-Tsu Cho
Chia-Ying Chang
Chia-Yu Chu
Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan
Dermatologica Sinica
generalized bullous fixed drug eruption
fixed drug eruption
Stevens-Johnson syndrome
toxic epidermal necrolysis
author_facet Cheng-Han Lee
Yi-Chun Chen
Yung-Tsu Cho
Chia-Ying Chang
Chia-Yu Chu
author_sort Cheng-Han Lee
title Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan
title_short Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan
title_full Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan
title_fullStr Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan
title_full_unstemmed Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan
title_sort fixed-drug eruption: a retrospective study in a single referral center in northern taiwan
publisher Wolters Kluwer Medknow Publications
series Dermatologica Sinica
issn 1027-8117
publishDate 2012-03-01
description Background/Objective: Fixed drug eruption (FDE) is a dermatosis characterized by recurrent patches or plaques at exactly the same sites with each administration of the causative drug. Vesicles or bullae may sometimes be found, and generalized bullous fixed drug eruption (GBFDE) may be confused with Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). This study aimed to investigate the clinical and pathologic features of FDE in Taiwan. Methods: A retrospective analysis evaluated patients with FDE in a referral center in Taiwan covering a period of 11 years. Clinical data, suspected etiologies, and pathology/patch test results were collected. We also compared the GBFDE cases with SJS/TEN overlap or TEN cases to find differentiating clues. Results: There were 39 FDE patients, including nine GBFDE cases. The most frequent causative drugs were non-steroidal anti-inflammatory drugs (five cases, 12.8%) and antibiotics (four cases, 10.3%). Extremities other than the hands (71.8%) were the most frequently affected sites, followed by the trunk (51.3%), mucosa (38.5%), and hands (33.3%). The average age of FDE patients was 52.2 years (median, 56 years; range, 4–86 years). Patients with GBFDE were significantly older than non-GBFDE patients (69.1±19.7 vs. 47.2±23.6, p=0.0124) and the trunk was more likely to be involved in GBFDE cases (88.9% vs. 40.0%, p=0.0197). GBFDE cases also showed tendency to have more mucosal involvement (66.7% vs. 30.0%, p=0.0631). Although similar to SJS/TEN, GBFDE cases had fewer constitutional symptoms, less mucosal involvement but had previous episodes. Histopathologically, the presence of more than two aggregated dyskeratotic keratinocytes (fire flag sign) in the epidermis was more frequently observed in SJS/TEN, whereas GBFDE had superficial and deep dermal infiltration of eosinophils and melanophages. Conclusion: FDE is one of the specialized cutaneous drug reactions and GBFDE should be kept in mind and differentiated from SJS/TEN.
topic generalized bullous fixed drug eruption
fixed drug eruption
Stevens-Johnson syndrome
toxic epidermal necrolysis
url http://www.sciencedirect.com/science/article/pii/S1027811712000109
work_keys_str_mv AT chenghanlee fixeddrugeruptionaretrospectivestudyinasinglereferralcenterinnortherntaiwan
AT yichunchen fixeddrugeruptionaretrospectivestudyinasinglereferralcenterinnortherntaiwan
AT yungtsucho fixeddrugeruptionaretrospectivestudyinasinglereferralcenterinnortherntaiwan
AT chiayingchang fixeddrugeruptionaretrospectivestudyinasinglereferralcenterinnortherntaiwan
AT chiayuchu fixeddrugeruptionaretrospectivestudyinasinglereferralcenterinnortherntaiwan
_version_ 1725798719980306432